genedrive plc (LON:GDR – Get Free Report)’s share price fell 15.1% on Thursday . The company traded as low as GBX 1.55 ($0.02) and last traded at GBX 1.55 ($0.02). 5,960,786 shares changed hands during trading, an increase of 109% from the average session volume of 2,857,632 shares. The stock had previously closed at GBX 1.83 ($0.02).
genedrive Stock Down 15.1 %
The business has a 50-day moving average of GBX 2.05 and a 200 day moving average of GBX 2.17. The company has a market capitalization of £8.80 million, a PE ratio of -0.43 and a beta of -0.04. The company has a debt-to-equity ratio of 0.35, a current ratio of 4.60 and a quick ratio of 5.52.
genedrive (LON:GDR – Get Free Report) last issued its quarterly earnings data on Thursday, March 27th. The company reported GBX (0.40) (($0.01)) earnings per share (EPS) for the quarter. genedrive had a negative return on equity of 191.22% and a negative net margin of 1,412.18%. Equities research analysts predict that genedrive plc will post 209.9999867 earnings per share for the current year.
About genedrive
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.
Recommended Stories
- Five stocks we like better than genedrive
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Top 3 Beverage Stocks Pouring Out Profits
- Why Are These Companies Considered Blue Chips?
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.